118 related articles for article (PubMed ID: 1545040)
1. Fluoxetine: no association with suicidality in obsessive-compulsive disorder.
Beasley CM; Potvin JH; Masica DN; Wheadon DE; Dornseif BE; Genduso LA
J Affect Disord; 1992 Jan; 24(1):1-10. PubMed ID: 1545040
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between fluoxetine and suicidality in bulimia nervosa.
Wheadon DE; Rampey AH; Thompson VL; Potvin JH; Masica DN; Beasley CM
J Clin Psychiatry; 1992 Jul; 53(7):235-41. PubMed ID: 1639742
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
Tollefson GD; Fawcett J; Winokur G; Beasley CM; Potvin JH; Faries DE; Rampey AH; Sayler ME
Ann Clin Psychiatry; 1993 Dec; 5(4):209-24. PubMed ID: 8312978
[TBL] [Abstract][Full Text] [Related]
5. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
6. The suicidality continuum in a large sample of obsessive-compulsive disorder (OCD) patients.
Velloso P; Piccinato C; Ferrão Y; Aliende Perin E; Cesar R; Fontenelle L; Hounie AG; do Rosário MC
Eur Psychiatry; 2016 Oct; 38():1-7. PubMed ID: 27606439
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
[TBL] [Abstract][Full Text] [Related]
8. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
Goldstein DJ; Rampey AH; Potvin JH; Masica DN; Beasley CM
J Clin Psychiatry; 1993 Aug; 54(8):309-16. PubMed ID: 8253699
[TBL] [Abstract][Full Text] [Related]
9. Alexithymia and perfectionism traits are associated with suicidal risk in patients with obsessive-compulsive disorder.
Kim H; Seo J; Namkoong K; Hwang EH; Sohn SY; Kim SJ; Kang JI
J Affect Disord; 2016 Mar; 192():50-5. PubMed ID: 26707347
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of obsessive compulsive disorder--experience with fluoxetine.
Wood A; Tollefson GD; Birkett M
Int Clin Psychopharmacol; 1993; 8(4):301-6. PubMed ID: 8277151
[TBL] [Abstract][Full Text] [Related]
11. Suicidal behavior in obsessive-compulsive disorder.
Kamath P; Reddy YC; Kandavel T
J Clin Psychiatry; 2007 Nov; 68(11):1741-50. PubMed ID: 18052568
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials.
Beasley CM; Ball SG; Nilsson ME; Polzer J; Tauscher-Wisniewski S; Plewes J; Acharya N
J Clin Psychopharmacol; 2007 Dec; 27(6):682-6. PubMed ID: 18004137
[TBL] [Abstract][Full Text] [Related]
13. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.
King RA; Riddle MA; Chappell PB; Hardin MT; Anderson GM; Lombroso P; Scahill L
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):179-86. PubMed ID: 2016219
[TBL] [Abstract][Full Text] [Related]
14. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder.
Tollefson GD; Rampey AH; Potvin JH; Jenike MA; Rush AJ; kominguez RA; Koran LM; Shear MK; Goodman W; Genduso LA
Arch Gen Psychiatry; 1994 Jul; 51(7):559-67. PubMed ID: 8031229
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration.
Brakoulias V; Starcevic V; Belloch A; Brown C; Ferrao YA; Fontenelle LF; Lochner C; Marazziti D; Matsunaga H; Miguel EC; Reddy YCJ; do Rosario MC; Shavitt RG; Shyam Sundar A; Stein DJ; Torres AR; Viswasam K
Compr Psychiatry; 2017 Jul; 76():79-86. PubMed ID: 28433854
[TBL] [Abstract][Full Text] [Related]
16. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.
Phillips KA; Kelly MM
Int Clin Psychopharmacol; 2009 Jan; 24(1):26-8. PubMed ID: 19060721
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group.
Montgomery SA; McIntyre A; Osterheider M; Sarteschi P; Zitterl W; Zohar J; Birkett M; Wood AJ
Eur Neuropsychopharmacol; 1993 Jun; 3(2):143-52. PubMed ID: 8364350
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.
Romano S; Goodman W; Tamura R; Gonzales J
J Clin Psychopharmacol; 2001 Feb; 21(1):46-52. PubMed ID: 11199947
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine and suicidal ideation.
Koizumi H
J Am Acad Child Adolesc Psychiatry; 1991 Jul; 30(4):695. PubMed ID: 1890110
[No Abstract] [Full Text] [Related]
20. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
Etain B; Bonnet-Perrin E
Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
